Diagnostic Consulting Network

October 2010 Meeting #3: The Latex Course

bofarrell — Wed, 08 Sep 2010 20:47:26 +0000

DCN will be presenting at the Bangs Latex Course “Designing Microsphere-Based Tests and Assays” to be held at Disney’s Grand Floridian Resort & Spa in Lake Buena Vista, Florida, from October 3 – 5, 2010.

DCN will be exhibiting and speaking on our expanding capabilities in the optimization and manufacturing of conjugates to fluorescent, visual and paramagnetic latex particles for use in diagnostic assays and prep scale separations. To set up an appointment to discuss your application, please contact Dr Roy Chung at rchung@dcndx.com or 760-804-3886.

For more details, or to register for the course, please click here

October 2010 Meeting #2: Inovatech Expo, Belo Horizonte, Brazil

bofarrell — Wed, 08 Sep 2010 20:37:11 +0000

Inovatech Expo, Belo Horizonte, Brazil. October 6-8, 2010

DCN will be exhibiting and presenting its capabilities at the Inovatech expo in Belo Horizonte, Brazil. To arrange an appointment to discuss collaboration or development of rapid diagnostic products at the meeting, please contact Dr Brendan O’Farrell at bofarrell@dcndx.com or by telephone at 949-872-8589.

For more details on the Expo, click here

October 2010 Meeting #1: BioDot San Francisco Workshop

bofarrell — Wed, 08 Sep 2010 20:35:55 +0000

A Practical, hands-on workshop on “Point of Care and Emerging Diagnostics” in San Francisco, October 11th – 13th 2010.

DCN is proudly co-sponsoring this BioDot Workshop and will be presenting a mini-seminar in association with Symbient Product Development, on the topic of:

Combining biology and engineering in the development of next generation rapid assay systems

Part 1: Critical considerations in the design and development of high sensitivity, quantitative lateral flow assay systems
- Brendan O’Farrell, PhD. Founding partner and CSO. Diagnostic Consulting Network

Part 2: The design and development of rapid assay devices with advanced functionality
- John Zeis. Founder and Chief Engineer. Symbient Product development

Part 3: Showcase: Development of a novel multiplexed, quantitative reader based point of care assay platform
- John Zeis and Brendan O’Farrell

DCN will also be hosting a practical demonstration of manufacturing methods for fluorescent, reader based assays, where workshop attendees will get hands-on experience with the equipment and processes for producing and reading fluorescent lateral flow assays.

Location: Marriott San Francisco Airport Hotel, San Francisco, CA.

Dates: October 11 – 13, 2010

For the detailed agenda click here

For Registration Information: www.biodot.com

DCN’s 2010 AACC Industry Workshop Slides Available Here

bofarrell — Tue, 03 Aug 2010 00:22:41 +0000

DCN and Symbient Product Development hosted a very successful Industry workshop at the AACC in Anaheim this year. Over 60 delegates attended the early morning session, which was on the topic of “Practical Development of High Sensitivity Fluorescent Rapid Assay Systems”. DCN and SPD demonstrated the key factors in designing and developing these types of products, and the critical importance of parallel development of novel devices and the tests that will operate within them. In the showcase section of the program, two development programs were highlighted, demonstrating the sensitive, quantitative and clinically relevant performance levels that can be developed in reader based lateral flow assays coupled with innovative device design. The slides from the workshop can be downloaded here.

Click the link below to download the slide presentation as a pdf:

DCN_Symbient AACC Workshop on Reader Based Rapid Assay Development [Compatibility Mode]

DCN at the AACC 2010 in Anaheim

bofarrell — Fri, 09 Jul 2010 19:49:47 +0000

Booth and Meetings

DCN will be exhibiting at the AACC 2010 in Anaheim, CA, July 27-29th 2010. Please visit us at booth 1016. If you would like to set up a meeting time, please contact Dr Brendan OFarrell at bofarrell@dcndx.com or at 760-804-3886.

Industry Workshop

DCN will be presenting an Industry Workshop in association with Symbient Product Development, where we will be showcasing our most recent developments in the areas of quantitative, high sensitivity rapid assay formats, particularly focused on fluorescent, reader based applications. Also on the agenda will be examples of sample handling and device design for better performance in POC systems.

Workshop Title: Practical Development of Quantitative, High Sensitivity Fluorescent Rapid Assay Systems

Location: Anaheim Marriott Hotel

Time and Date: July 28th, 2010 at 7am. Breakfast will be provided.

Dr Hans Boehringer joins DCN as VP of Technology Development

bofarrell — Fri, 09 Jul 2010 19:28:48 +0000

DCN is pleased to welcome on board Dr Hans Boehringer in the position of Vice President of Technology Development. Hans most recently held the position of R&D Director at Genzyme Diagnostics in San Diego, preceded by Senior Scientist positions at Quidel and Pacific Biotech. Hans brings considerable experience in project management and in the development, transfer and commercialization of rapid diagnostics to DCN’s team, adding to the already considerable depth of experience on board. He will be working closely with Dr Roy Chung, our Vice President of R&D, in implementing specialized platform development projects.

IVD Research Director

mikesurmanian — Wed, 10 Mar 2010 22:31:41 +0000

Most recently he was Scientific R&D Director at Genzyme Diagnostics in San Diego, CA. He was responsible for the development of Influenza and other respiratory virus rapid tests, established a cell and viral culture laboratory and was instrumental in introducing automation for the development and manufacture of lateral flow tests. Additional experience includes the instrument and assay development for a quantitative rapid cardiac test. Prior to Genzyme, he was the R&D Project Director at Quidel Corp. where he was responsible for the product development of rapid test in the women’s health business group. Before joining Quidel he was a Senior Research Scientist/Project Manager with Pacific Biotech, Inc. where he developed assays for Influenza, Chlamydia, Strep A as well as immuno fecal occult blood.

Biotech and IVD Operations Executive

mikesurmanian — Wed, 10 Mar 2010 22:30:54 +0000

Over 25 years experience building, managing, and improving manufacturing, quality, and supply chain systems and processes in innovative IVD and RUO diagnostics companies. Skilled in new product development processes, technology transfer, commercialization and scale-up. Expertise in identifying and eliminating defects and waste in pursuit of world-class cost, quality, and service. Hands-on problem solver, leader and facilitator of continuous and breakthrough improvement activities.

Assay Development and Project Management Professional

mikesurmanian — Wed, 03 Mar 2010 03:30:11 +0000

Over 18 years of research and product development experience in the diagnostics industries. Most recently he was Scientific R&D Director at Genzyme Diagnostics in San Diego, CA. He was responsible for the development of Influenza and other respiratory virus rapid tests, established a cell and viral culture laboratory and was instrumental in introducing automation for the development and manufacture of lateral flow tests. Additional experience includes the instrument and assay development for a quantitative rapid cardiac test. Prior to Genzyme, he was the R&D Project Director at Quidel Corp. where he was responsible for the product development of rapid test in the women’s health business group. Before joining Quidel he was a Senior Research Scientist/Project Manager with Pacific Biotech, Inc. where he developed assays for Influenza, Chlamydia, Strep A as well as immuno fecal occult blood.

DCN IS MOVING

mikesurmanian — Mon, 19 Oct 2009 19:35:28 +0000

DCN is moving to its new 8000 square foot facility on 9 November 2009. The address is 6354 Corte del Abeto,Suite B, Carlsbad, CA 92011. Other contact information will remain the same. (Telephone +1-760-804-3886. Fax +1-760-804-3866.) Watch for more details on the new facility and for the upcoming Open House to celebrate the move.